Clearmind Medicine Ownership 2024 | Who Owns Clearmind Medicine Now?

Institutional Ownership

9.70%

Institutional Holders

5.00

Clearmind Medicine Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORSHARES INVESTMENTS LLC	6.67%	0.06%	153,257	153,257	100.00%	176,246,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	2.22%	-	51,010	51,010	100.00%	58,661,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.49%	-	11,363	11,363	100.00%	13,067,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.20%	0.00%	4,607	4,607	100.00%	5,000	Mar 31, 2023
UBS GROUP AG	0.12%	-	2,735	877	47.20%	3,145,000	Mar 31, 2023
WALLEYE CAPITAL LLC	-	-	-	-44,351	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-700	-100.00%	-	Mar 31, 2023

Clearmind Medicine's largest institutional shareholder is ADVISORSHARES INVESTMENTS LLC, holding 6.67% of the company's total share outstanding, currently valued at $176.25M. The top 10 institutional shareholders own together 9.70% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORSHARES INVESTMENTS LLC	6.67%	0.06%	153,257	153,257	100.00%	176,246,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.20%	0.00%	4,607	4,607	100.00%	5,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	2.22%	-	51,010	51,010	100.00%	58,661,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.49%	-	11,363	11,363	100.00%	13,067,000	Mar 31, 2023
UBS GROUP AG	0.12%	-	2,735	877	47.20%	3,145,000	Mar 31, 2023
WALLEYE CAPITAL LLC	-	-	-	-44,351	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-700	-100.00%	-	Mar 31, 2023

The largest Clearmind Medicine shareholder by % of total assets is ADVISORSHARES INVESTMENTS LLC. The company owns 153.26K shares of Clearmind Medicine (CMND), representing 0.06% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORSHARES INVESTMENTS LLC	6.67%	0.06%	153,257	153,257	100.00%	176,246,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	2.22%	-	51,010	51,010	100.00%	58,661,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.49%	-	11,363	11,363	100.00%	13,067,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.20%	0.00%	4,607	4,607	100.00%	5,000	Mar 31, 2023
UBS GROUP AG	0.12%	-	2,735	877	47.20%	3,145,000	Mar 31, 2023
MORGAN STANLEY	-	-	-	-700	-100.00%	-	Mar 31, 2023
WALLEYE CAPITAL LLC	-	-	-	-44,351	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Clearmind Medicine's largest institutional buyer is ADVISORSHARES INVESTMENTS LLC. The company purchased 153.26K stocks of CMND, valued at $176.25M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WALLEYE CAPITAL LLC	-	-	-	-44,351	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-700	-100.00%	-	Mar 31, 2023
UBS GROUP AG	0.12%	-	2,735	877	47.20%	3,145,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.20%	0.00%	4,607	4,607	100.00%	5,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.49%	-	11,363	11,363	100.00%	13,067,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	2.22%	-	51,010	51,010	100.00%	58,661,000	Mar 31, 2023
ADVISORSHARES INVESTMENTS LLC	6.67%	0.06%	153,257	153,257	100.00%	176,246,000	Mar 31, 2023

As of Mar 31 2023, Clearmind Medicine's biggest institutional seller is WALLEYE CAPITAL LLC. The company sold -44.35K shares of CMND, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORSHARES INVESTMENTS LLC	6.67%	0.06%	153,257	153,257	100.00%	176,246,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	2.22%	-	51,010	51,010	100.00%	58,661,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.49%	-	11,363	11,363	100.00%	13,067,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.20%	0.00%	4,607	4,607	100.00%	5,000	Mar 31, 2023

Clearmind Medicine's largest new institutional shareholder by number of shares is ADVISORSHARES INVESTMENTS LLC, purchased 153.26K shares, valued at $176.25M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WALLEYE CAPITAL LLC	-	-	-	-44,351	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-700	-100.00%	-	Mar 31, 2023

Clearmind Medicine's largest sold out institutional shareholder by shares sold is WALLEYE CAPITAL LLC, sold -44.35K shares, valued at -, as of undefined.

Clearmind Medicine Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
AdvisorShares Trust	0.03%	123,257	-	-	Mar 28, 2024
AdvisorShares Trust	0.03%	112,693	20,000	21.58%	Mar 28, 2024
FIDELITY COMMONWEALTH TRUST	0.02%	63,904	-	-	Feb 29, 2024
FIDELITY COMMONWEALTH TRUST	0.01%	16,234	6,552	67.67%	Feb 29, 2024

Clearmind Medicine's largest mutual fund holder by % of total assets is "AdvisorShares Trust", owning 123.26K shares, compromising 0.03% of its total assets.

Clearmind Medicine Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	5	66.67%
31 Dec, 22	3	-

As of 31 Mar 23, 5 institutions are holding Clearmind Medicine's shares, representing an increase of 66.67% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	222,972	375.33%
31 Dec, 22	46,909	-

Clearmind Medicine (CMND) has 222.97K shares outstanding as of 31 Mar 23, up 375.33% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	9.70%	168.94%
31 Dec, 22	3.61%	-

As of 31 Mar 23, Clearmind Medicine is held by 9.70% institutional shareholders, representing a 168.94% growth compared to 31 Dec 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	1	-
31 Dec, 22	-	-

1 institutional shareholders have increased their position in CMND stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	-	-
31 Dec, 22	-	-

- institutional shareholders have reduced their position in CMND stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	5	66.67%	222,972	375.33%	9.70%	168.94%	1	-	-	-
31 Dec, 22	3	-	46,909	-	3.61%	-	-	-	-	-

Clearmind Medicine Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
May 05, 2017	Lamadrid David	director, 10 percent owner, officer	CEO and President		Sell	-	-	-	428,572

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 16, 2017	Lamadrid David	director, 10 percent owner, officer	CEO and President	A-Award	Buy	857,143	$0.35	$300.00K	857,143
May 05, 2017	Lamadrid David	director, 10 percent owner, officer	CEO and President		Buy	-	-	-	6,142,857
May 05, 2017	Lamadrid David	director, 10 percent owner, officer	CEO and President		Sell	-	-	-	428,572
May 05, 2017	Lamadrid David	director, 10 percent owner, officer	CEO and President		Buy	-	-	-	187,500

The last insider sell of Clearmind Medicine's stock was made by Lamadrid David on May 05 2017, selling - shares at - per share (valued at -).

Clearmind Medicine Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio

Clearmind Medicine Peer Ownership

Ticker	Company
MGTA	Dianthus Therapeutics, Inc.
CNSP	CNS Pharmaceuticals, Inc.
BWV	Onconetix, Inc.
PXMD	PaxMedica, Inc. Common Stock
REVB	Revelation Biosciences, Inc.
QNRX	Quoin Pharmaceuticals, Ltd.
HILS	Tharimmune, Inc.
VRAX	Virax Biolabs Group Limited
EFTR	eFFECTOR Therapeutics, Inc.
IMMX	Immix Biopharma, Inc.
SONN	Sonnet BioTherapeutics Holdings, Inc.
WINT	Windtree Therapeutics, Inc.
UNCY	Unicycive Therapeutics, Inc.
BXRX	Baudax Bio, Inc.
CDIO	Cardio Diagnostics Holdings, Inc.

CMND Ownership FAQ

Who Owns Clearmind Medicine?

Clearmind Medicine is owned by institutional shareholders (9.70%), insiders (0.00%), and public (90.30%). The largest institutional shareholder of Clearmind Medicine is ADVISORSHARES INVESTMENTS LLC (6.67% of total shares) and the top mutual fund owner is AdvisorShares Trust (0.03% of total shares).

Who are the major institutional shareholders of Clearmind Medicine?

Clearmind Medicine's major institutional shareholders are ADVISORSHARES INVESTMENTS LLC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, TOWER RESEARCH CAPITAL LLC (TRC), and UBS GROUP AG. The top five shareholders own together 9.70% of the company's share outstanding.

How many Clearmind Medicine shareholders are there?

As of Mar 2023, there are 5 institutional shareholders of Clearmind Medicine.

What percentage of Clearmind Medicine is owned by ADVISORSHARES INVESTMENTS LLC?

ADVISORSHARES INVESTMENTS LLC owns 153.26K shares of Clearmind Medicine, representing 6.67% of the company's total shares outstanding, valued at $176.25M (as of Mar 2023).

What percentage of Clearmind Medicine is owned by GEODE CAPITAL MANAGEMENT, LLC?

As of Mar 2023, GEODE CAPITAL MANAGEMENT, LLC holds 51.01K shares of Clearmind Medicine (CMND), compromising 2.22% of the company, valued at $58.66M.

What percentage of Clearmind Medicine is owned by CITADEL ADVISORS LLC?

CITADEL ADVISORS LLC is the third largest holder of Clearmind Medicine. The company owns 11.36K of the company's shares outstanding (worth $13.07M).